Researchers showed that pharmacological inhibition of LSD1 (LSD1i) in CD8 + T cell in the context of adoptive T cell therapy elicited phenotypic and functional alterations, resulting in a robust antitumor immunity in preclinical models in female mice.
[Nature Communications]
